Radiotherapy Twice A Day Halves Treatment Time
|
By MedImaging International staff writers Posted on 16 Jun 2016 |
|
Radiotherapy (RT) once a day for six and a half weeks or twice a day for three weeks offer equal benefit in non-metastatic small cell lung cancer (SCLC), according to a new study.
Researchers at the University of Manchester (United Kingdom), the Catalan Institute of Oncology (ICO; Barcelona, Spain), and other institutions conducted a study that recruited 550 patients diagnosed with SCLC from 74 centers in eight countries between 2008 and 2013. The patients were randomized to receive either concurrent twice-daily RT over three weeks or concurrent once-daily RT over 6.5 weeks, both starting on day 22 of cycle 1. Patients were followed up until death. The primary end point was overall survival.
The results showed that survival in both groups was similar, with 56% of patients who had RT twice a day surviving for two years, compared with 51% of those given it once a day. The majority of side effects from RT were similar in both groups, apart from neutropenia, which happened more often in twice daily treatment group. The trial also identified the optimum amount of RT as 66 grays once a day and 45 grays twice a day. The study was presented at the American Society of Clinical Oncology (ASCO) cancer conference, held during June 2016 in Chicago (IL, USA).
“Before this study, it was unclear whether having radiotherapy once or twice a day helped more patients survive for longer, and what level of side effects was expected with modern radiotherapy techniques,” said lead author Professor Corinne Faivre-Finn, MD, PhD, of the University of Manchester. “We're pleased to provide answers to these questions, and our results have already begun to change practice around the world. Small cell lung cancer patients will be able to choose between a shorter course of radiotherapy given twice a day and a longer course given once a day.”
Primary lung cancers are malignant carcinomas that derive from epithelial cells, with the main types being SCLC and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
Related Links:
University of Manchester
Catalan Institute of Oncology
Researchers at the University of Manchester (United Kingdom), the Catalan Institute of Oncology (ICO; Barcelona, Spain), and other institutions conducted a study that recruited 550 patients diagnosed with SCLC from 74 centers in eight countries between 2008 and 2013. The patients were randomized to receive either concurrent twice-daily RT over three weeks or concurrent once-daily RT over 6.5 weeks, both starting on day 22 of cycle 1. Patients were followed up until death. The primary end point was overall survival.
The results showed that survival in both groups was similar, with 56% of patients who had RT twice a day surviving for two years, compared with 51% of those given it once a day. The majority of side effects from RT were similar in both groups, apart from neutropenia, which happened more often in twice daily treatment group. The trial also identified the optimum amount of RT as 66 grays once a day and 45 grays twice a day. The study was presented at the American Society of Clinical Oncology (ASCO) cancer conference, held during June 2016 in Chicago (IL, USA).
“Before this study, it was unclear whether having radiotherapy once or twice a day helped more patients survive for longer, and what level of side effects was expected with modern radiotherapy techniques,” said lead author Professor Corinne Faivre-Finn, MD, PhD, of the University of Manchester. “We're pleased to provide answers to these questions, and our results have already begun to change practice around the world. Small cell lung cancer patients will be able to choose between a shorter course of radiotherapy given twice a day and a longer course given once a day.”
Primary lung cancers are malignant carcinomas that derive from epithelial cells, with the main types being SCLC and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
Related Links:
University of Manchester
Catalan Institute of Oncology
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Thyroid Shield
Standard Thyroid Shield
New
Digital Radiography Generator
meX+20BT lite
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection
Channels
MRI
view channel
Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
Magnetic Resonance Imaging (MRI) has significantly transformed healthcare, providing a noninvasive, radiation-free method for detailed imaging. It is especially promising for the future of medical diagnosis... Read more
World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
The world's first whole-body ultra-high field (UHF) MRI has officially come to market, marking a remarkable advancement in diagnostic radiology. United Imaging (Shanghai, China) has secured clearance from the U.... Read more
Ultrasound
view channel.jpg "Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)")
Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease
Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more
Super-Resolution Imaging Technique Could Improve Evaluation of Cardiac Conditions
The heart depends on efficient blood circulation to pump blood throughout the body, delivering oxygen to tissues and removing carbon dioxide and waste. Yet, when heart vessels are damaged, it can disrupt... Read more
First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity
Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more
Nuclear Medicine
view channel
New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more![Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)](https://globetechcdn.com/mobile_medicalimaging/images/stories/articles/article_images/2024-05-09/JNM May 2024 Hofman.jpg "Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)"){kind=small}
New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more
New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
Imaging inflammation using traditional radiological techniques presents significant challenges, including radiation exposure, poor image quality, high costs, and invasive procedures. Now, new contrast... Read more
New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read moreGeneral/Advanced Imaging
view channel
Bone Density Test Uses Existing CT Images to Predict Fractures
Osteoporotic fractures are not only devastating and deadly, especially hip fractures, but also impose significant costs. They rank among the top chronic diseases in terms of disability-adjusted life years... Read more
AI Predicts Cardiac Risk and Mortality from Routine Chest CT Scans
Heart disease remains the leading cause of death and is largely preventable, yet many individuals are unaware of their risk until it becomes severe. Early detection through screening can reveal heart issues,... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Hologic, Inc. (Marlborough, MA, USA) has entered into a definitive agreement to acquire Endomagnetics Ltd. (Cambridge, UK), a privately held developer of breast cancer surgery technologies, for approximately... Read more
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
